Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cashlez Worldwide Indonesia Tbk. (CASH) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Cashlez Worldwide Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Cashlez Worldwide Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Cashlez Worldwide Indonesia Tbk. trades at Rp204 (market cap 490.42B, 725.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (848.2K versus 725.1K). Which is the better fit depends on your goals.

CASHLABS
Market Cap
490.42B651.75B
Volume
725.1K848.2K
Lot
7.25K8.48K
Turnover
145.49M140.51M
Average Price
200.65165.66
Value
145.49M140.51M
Indicative Equilibrium Price
204168
Indicative Equilibrium Volume
350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CASH
View details
LABS
View details

About Cashlez Worldwide Indonesia Tbk.

PT Cashlez Worldwide Indonesia Tbk (the Company) was established based on Notarial DeedNo. 1 dated January 12, 2015 of public notary Novita Puspitarini, S.H. The Company started its commercial operations in 2016.

Read more on CASH

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS